Cited by 18Receptor Mechanisms and SignalingAdvanced Fluorescence Microscopy TechniquesThyroid Disorders and Treatments

Evidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level

Open access
Fischer, Jana, Kleinau, Gunnar, Rutz, Claudia, Zwanziger, Denise, Khajavi, Noushafarin, Müller, Anne, Rehders, Maren, Brix, Klaudia +6 more·2018·Cellular and Molecular Life Sciences

Abstract

G-protein-coupled receptors (GPCRs) can constitute complexes with non-GPCR integral membrane proteins, while such interaction has not been demonstrated at a single molecule level so far. We here investigated the potential interaction between the thyrotropin receptor (TSHR) and the monocarboxylate transporter 8 (MCT8), a member of the major facilitator superfamily (MFS), using fluorescence cross-correlation spectroscopy (FCCS). Both the proteins are expressed endogenously on the basolateral plasma membrane of the thyrocytes and are involved in stimulation of thyroid hormone production and release. Indeed, we demonstrate strong interaction between both the proteins which causes a suppressed activation of G q/11 by TSH-stimulated TSHR. Thus, we provide not only evidence for a novel interaction between the TSHR and MCT8, but could also prove this interaction on a single molecule level. Moreover, this interaction forces biased signaling at the TSHR. These results are of general interest for both the GPCR and the MFS research fields.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-017-2728-1

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MCT8 and TSHR form a heterodimeric complex that directly modulates the selectivity of TSHR-mediated signal transduction pathways, with MCT8 profoundly reducing TSH-induced Gαq/11 signaling without affecting Gαs-mediated cAMP accumulation.

    “The two can form heterodimeric complex which directly modulates the selectivity of TSHR-mediated signal transduction pathways. MCT8 profoundly reduces the capacity of TSH to induce Gαq/11-mediated signaling at TSHR, without affecting Gαs-mediated cAMP accumulation (196).”

    From Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion (2022) · cites this paper as [196]

    The Results (page not supplied) report a 60–70% reduction in the IP3 measure of Gq/11 signaling with MCT8 co-expression, while the slight reduction in TSH-induced cAMP accumulation was not statistically significant. The Discussion (page not supplied) says the TSHR/MCT8 complex *could* directly modulate pathway selectivity and leaves its exact heteromeric nature for future study; the claim presents direct modulation and a heterodimeric complex as established. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. [1]George SR, O’Dowd BF, Lee SP. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov. 2002;1:808–820. doi: 10.1038/nrd913. [DOI] [PubMed] [Google Scholar] · DOI
  2. [2]Calebiro D, et al. Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci USA. 2013;110:743–748. doi: 10.1073/pnas.1205798110. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  3. [3]Lambert NA. GPCR dimers fall apart. Sci Signal. 2010;3:pe12. doi: 10.1126/scisignal.3115pe12. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  4. [4]Teichmann A, et al. The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum. J Biol Chem. 2014;289:24250–24262. doi: 10.1074/jbc.M114.553644. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  5. [5]Doupnik CA. GPCR-Kir channel signaling complexes: defining rules of engagement. J Recept Signal Transduct Res. 2008;28:83–91. doi: 10.1080/10799890801941970. [DOI] [PubMed] [Google Scholar] · DOI
  6. [6]Benleulmi-Chaachoua A, et al. Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons. J Pineal Res. 2016;60:95–108. doi: 10.1111/jpi.12294. [DOI] [PubMed] [Google Scholar] · DOI
  7. [7]Dehvari N, et al. beta(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail. Br J Pharmacol. 2012;165:1442–1456. doi: 10.1111/j.1476-5381.2011.01647.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  8. [8]Xie Z, Westmoreland SV, Miller GM. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther. 2008;325:629–640. doi: 10.1124/jpet.107.135079. [DOI] [PubMed] [Google Scholar] · DOI
  9. [9]Law CJ, Maloney PC, Wang DN. Ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol. 2008;62:289–305. doi: 10.1146/annurev.micro.61.080706.093329. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  10. [10]Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 1992;13:596–611. doi: 10.1210/edrv-13-3-596. [DOI] [PubMed] [Google Scholar] · DOI
  11. [11]Biebermann H, Winkler F, Kleinau G. Genetic defects, thyroid growth and malfunctions of the TSHR in pediatric patients. Front Biosci. 2010;15:913–933. doi: 10.2741/3654. [DOI] [PubMed] [Google Scholar] · DOI
  12. [12]Latif R, Graves P, Davies TF. Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes. J Biol Chem. 2001;276:45217–45224. doi: 10.1074/jbc.M103727200. [DOI] [PubMed] [Google Scholar] · DOI
  13. [13]Davies T, Marians R, Latif R. The TSH receptor reveals itself. J Clin Invest. 2002;110:161–164. doi: 10.1172/JCI0216234. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  14. [14]Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003;278:40128–40135. doi: 10.1074/jbc.M300909200. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  15. [15]Kinne A, Kleinau G, Hoefig CS, Gruters A, Kohrle J, Krause G, Schweizer U. Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem. 2010;285:28054–28063. doi: 10.1074/jbc.M110.129577. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  16. [16]Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S. Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J Clin Invest. 2010;120:3377–3388. doi: 10.1172/JCI42113. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  17. [17]Sequeira M, Jasani B, Fuhrer D, Wheeler M, Ludgate M. Demonstration of reduced in vivo surface expression of activating mutant thyrotrophin receptors in thyroid sections. Eur J Endocrinol. 2002;146:163–171. doi: 10.1530/eje.0.1460163. [DOI] [PubMed] [Google Scholar] · DOI
  18. [18]Bartholomaus I, et al. Glycine transporter dimers: evidence for occurrence in the plasma membrane. J Biol Chem. 2008;283:10978–10991. doi: 10.1074/jbc.M800622200. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  19. [19]Keller T, et al. The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization. J Biol Chem. 2011;286:37874–37886. doi: 10.1074/jbc.M111.289330. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  20. [20]Yin Y, He X, Szewczyk P, Nguyen T, Chang G. Structure of the multidrug transporter EmrD from Escherichia coli. Science. 2006;312:741–744. doi: 10.1126/science.1125629. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  21. [21]Seidel S, et al. Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol. 2005;67:140–151. doi: 10.1124/mol.67.1.. [DOI] [PubMed] [Google Scholar] · DOI
  22. [22]Kasai RS, Suzuki KG, Prossnitz ER, Koyama-Honda I, Nakada C, Fujiwara TK, Kusumi A. Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging. J Cell Biol. 2011;192:463–480. doi: 10.1083/jcb.201009128. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  23. [23]Nyfeler B, Michnick SW, Hauri HP. Capturing protein interactions in the secretory pathway of living cells. Proc Natl Acad Sci USA. 2005;102:6350–6355. doi: 10.1073/pnas.0501976102. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  24. [24]Elson EL. Fluorescence correlation spectroscopy measures molecular transport in cells. Traffic. 2001;2:789–796. doi: 10.1034/j.1600-0854.2001.21107.x. [DOI] [PubMed] [Google Scholar] · DOI
  25. [25]Schwille P, Korlach J, Webb WW. Fluorescence correlation spectroscopy with single-molecule sensitivity on cell and model membranes. Cytometry. 1999;36:176–182. doi: 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar] · DOI
  26. [26]Haustein E, Schwille P. Ultrasensitive investigations of biological systems by fluorescence correlation spectroscopy. Methods. 2003;29:153–166. doi: 10.1016/S1046-2023(02)00306-7. [DOI] [PubMed] [Google Scholar] · DOI
  27. [27]Teichmann A, Rutz C, Kreuchwig A, Krause G, Wiesner B, Schulein R. The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization. J Biol Chem. 2012;287:27265–27274. doi: 10.1074/jbc.M112.360594. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  28. [28]Fischer J, et al. Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations. J Mol Endocrinol. 2015;54:39–50. doi: 10.1530/JME-14-0272. [DOI] [PubMed] [Google Scholar] · DOI
  29. [29]Muller A, et al. G-protein coupled receptor 83 (GPR83) signaling determined by constitutive and zinc(II)-induced activity. PLoS One. 2013;8:e53347. doi: 10.1371/journal.pone.0053347. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  30. [30]Winkler F, et al. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6. J Clin Endocrinol Metab. 2010;95:3605–3610. doi: 10.1210/jc.2010-0112. [DOI] [PubMed] [Google Scholar] · DOI
  31. [31]Biebermann H, Krude H, Elsner A, Chubanov V, Gudermann T, Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes. 2003;52:2984–2988. doi: 10.2337/diabetes.52.12.2984. [DOI] [PubMed] [Google Scholar] · DOI
  32. [32]Zwanziger D, Rakov H, Engels K, Moeller LC, Fuhrer D. Sex-dependent claudin-1 expression in the liver of euthyroid and hypothyroid mice. Eur Thyroid J. 2015;4:67–73. doi: 10.1159/000431316. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  33. [33]Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45. doi: 10.1093/nar/29.9.e45. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  34. [34]Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper—excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26:509–515. doi: 10.1023/B:BILE.0000019559.84305.47. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  35. [35]Kleinau G, Neumann S, Gruters A, Krude H, Biebermann H. Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev. 2013;34:691–724. doi: 10.1210/er.2012-1072. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  36. [36]Kero J, Ahmed K, Wettschureck N, Tunaru S, Wintermantel T, Greiner E, Schutz G, Offermanns S. Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J Clin Invest. 2007;117:2399–2407. doi: 10.1172/JCI30380. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  37. [37]Badziong J, et al. Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism. Eur J Endocrinol. 2017;177:243–250. doi: 10.1530/EJE-17-0279. [DOI] [PubMed] [Google Scholar] · DOI
  38. [38]Allen MD, Neumann S, Gershengorn MC. Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J. 2011;25:3687–3694. doi: 10.1096/fj.11-188961. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page

Cited by

Sorted by citations

Authors
Fischer, J., Kleinau, G., Rutz, C., Zwanziger, D., Khajavi, N., Müller, A., Rehders, M., Brix, K., Worth, C. L., Führer, D., Krude, H., Wiesner, B., Schülein, R., & Biebermann, H.
Affiliations
  • Charité – Universitätsmedizin Berlin (DE)
  • Leibniz-Forschungsinstitut für Molekulare Pharmakologie (DE)
  • Essen University Hospital (DE)
  • Constructor University (DE)
Corresponding author
  • Schülein, Ralf
  • Biebermann, Heike
Venue
Cellular and Molecular Life Sciences
Published
2017-12-30
Volume
75
Issue
12
Pages
2227-2239
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W2780519805
Cited by
18
References
0
Citations by year
2024: 3 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 1
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Life Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
TSH receptor, MCT8, major facilitator superfamily, biased signaling, thyroid hormone transport, thyroid follicular cells, basolateral membrane
MeSH terms
Animals, Chlorocebus aethiops, Humans, Receptors, Thyrotropin, Thyroid Gland, Signal Transduction, Gene Expression, COS Cells, Monocarboxylic Acid Transporters, Symporters, Protein Multimerization, HEK293 Cells, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review